Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.

1. Quality Management System (QMS)
2. Non-serious AESI
3. Individual Case Safety Report (ICSR)
4. Identified Risk
5. Global Patient Safety
6. International Conference on Harmonization (ICH)
7. Product Safety Strategy
8. Chief Safety Officer
9. Qualified Person for Pharmacovigilance
10. Solicited reports
11. Business Continuity Plan
12. Urgent Safety Measure
13. Important Potential Risks
14. Organized Data Collection Program
15. Business Partner
16. Signal Management Process
17. Drug Substance
18. Reference Safety Information
19. Post-Marketing Surveillance
20. Developmental Risk Management Plan
21. Refuted Signal
22. Quality Assurance
23. Investigator’s Brochure
24. Periodic Safety Update Report
25. Marketing Authorization Holder
26. Pharmacovigilance
27. Observational study
28. Overdose
29. Other Safety Issue
30. Suspected Unexpected Serious Adverse Reaction (SUSAR)
31. Clinical Trial Application
32. Signal Prioritization
33. Health Authority
34. Institutional Review Board
35. Contract Research Organization (CRO)
36. Safety Assessment Team
37. Signal Validation
38. Benefit-risk analysis
39. Drug Abuse
40. Post-authorization Safety Study
41. Dear Investigator Letter
42. Investigational Medicinal Product
43. Affiliate
44. Council for International Organizations of Medical Sciences
45. Serious Adverse Event
46. Validated Signal
47. Safety Management Team
48. Risk Management Plan
49. Signal Assessment
50. Company Core Data Sheet
51. process excellence
52. Expectedness
53. Safety Information
54. Pharmacovigilance
55. Sponsor
56. Clinical Development Program
57. Regulatory authority
58. Unexpected Events
59. Off-label use
60. Signal Detection
61. Development Safety Update Report
62. Global Safety Database
63. Safety Data Exchange Agreement
64. Pharmacovigilance System Master File
65. Signal Detection Plan
66. Local Safety Representative
67. Monitoring Plan
68. Adverse Event of Special Interest (AESI)
69. alliance management
70. Risk Management
71. Good Pharmacovigilance Practice
72. Occupational exposure
73. Individual Case Safety Report
74. Comparator Product
75. Company Safety Committee
76. Data Lock Point
77. Company Core Safety Information
78. Pharmacoepidemiology
79. Pharmacovigilance System
80. Country Safety Lead/Manager
81. Non-Interventional Study
82. Blinding or Masking
83. Drug Adverse Event Reporting System
84. Safety Signal
85. Product Recall
86. World Health Organization
87. Healthcare Professional
88. Medicines and Healthcare Regulatory Agency
89. Product
90. Special Situations
91. Adverse Event (AE)
92. Product Quality Complaint
93. National Medical Product Administration
94. GVP Module I
95. Investigator
96. Tolerability
97. Causality Assessment
98. Adverse Event Report Number
99. Protocol
100. periodic safety update report (PSUR)
101. Clinical Study
102. BeiGene Representative
103. Interventional Study
104. Labeled or unlabeled
105. Periodic Benefit-Risk Evaluation Report
106. background rates
107. Aggregate Safety Report (ASR)
108. EudraVigilance
109. Medical Review
110. Literature Report
111. Risk Communication
112. Investigational New Drug Application
113. Spontaneous (Unsolicited) report
114. Adverse Drug Reaction (ADR)
115. New Drug Application
116. Non-validated signal
117. PV Agreement
118. Development International Birth Date
119. Clinical Trial
120. Side effect
121. Medical Dictionary for Regulatory Activities (MedRA)
122. Corrective and Preventive Action (CAPA)
123. Listedness/ expectedness
124. Clinical Study Number
125. Drug Product
126. Good Clinical Practice
127. Patient Safety
128. Informed Consent
129. Risk-Benefit Balance
130. Subject Matter Expert